Skip to content

Clinical trials

Completed Inflammatory Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Status: Completed Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20035
20053
20062
20074
20092
20103
20121
20131
20151
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
City of Hope Medical Center4
Dana-Farber Cancer Institute2
GlaxoSmithKline2
H. Lee Moffitt Cancer Center and Research Institute2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
SWOG Cancer Research Network2
Alliance for Clinical Trials in Oncology1
Case Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms37
Breast Neoplasms35
Breast Neoplasms, Male9
Bile Duct Neoplasms3
Carcinoma, Ductal, Breast3
Carcinoma, Hepatocellular3
Carcinoma, Lobular3
Carcinoma, Medullary3
Carcinoma, Non-Small-Cell Lung3
Colonic Neoplasms3

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.